Vitamin D in Sepsis - A Randomised Control Trial
Phase 2
- Conditions
- Health Condition 1: A418- Other specified sepsis
- Registration Number
- CTRI/2019/01/017066
- Lead Sponsor
- Dr Siddhant J Thampi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Aged > 18 with suspected Sepsis
2. Sepsis will be defined by the following : Presence of SIRS presumed or confirmed to be due to an infectious etiology AND
3. qSOFA more than or equal to 2.
Exclusion Criteria
1. Pregnancy
2. Brain injury after cardiopulmonary arrest prior to recruitment
3. Patients who are severely ill with APACHE II > 40 (85% Mortality) and unlikely to survive for more than 24 hours
4. Current hypercalcemia > 10.8 mg/dL
5. History of therapy with high-dose vitamin D3 in the past 6 months
6. Patients with Platelets < 50,000 or INR > 1.3
7. CKD Patients who have received any form of Vitamin-D Supplementation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method